SAT0360 A summary of clinical evidence for commonly used uricosurics for gout in europe
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.3026
Abstract: Background Uricosurics (benzbromarone, probenecid, or sulfinpyrazone) are recommended for second-line treatment of gout if treatment target cannot be achieved with allopurinol or if allopurinol cannot be tolerated. While some uricosurics have been available since the… read more here.
Keywords: quality; summary clinical; evidence; plus allopurinol ... See more keywords